In serum, GFAP levels peak in acute TBI fatalities (survival times of less than 2 h) and, with increasing TBI survival times up to 456 h, approximate the concentrations of the control group (acute myocardial infarction, diffuse cerebral hypoxia, and isolated torso trauma) [11]. The gene discussed is GFAP; the disease is acute myocardial infarction.